Imedex® is an industry leader in providing certified, independent continuing medical education to health care professionals.

August 25, 2018

Dallas, Texas

Continuing Education

ACCMEPhysicians
Imedex, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Imedex designates this live for a maximum of 7.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.




ACCMEMaintenance of Certification
ABIM MOC Successful completion of this CME activity enables a participant to earn up to 7.0 MOC points towards the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is Imedex’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC Points.
Participants will have only 60 days following the activity to claim MOC points. (Deadline: October 25, 2018.)


ACCMEPHARMACY
In support of improving patient care, this activity has been planned and implemented by North American Center for Continuing Medical Education (NACCME) and Imedex. NACCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

This knowledge-based activity (JA0006201-9999-18-052-L01-P) is approved for 7.0 contact hours (0.7 CEUs) of continuing pharmacy education. Participants must attend sessions and complete an evaluation in order to claim credit. Participants will have only 60 days following the activity to claim credit (Deadline: October 25, 2018.)




ACCMENURSING
In support of improving patient care, this activity has been planned and implemented by North American Center for Continuing Medical Education (NACCME) and the Imedex. NACCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

This continuing nursing education activity awards 7.0 contact hours.

Provider approved by the California Board of Registered Nursing, Provider #13255 for 7.0 contact hours.

Pharmacology hours will be updated on site, upon final approval of conference content.



Who Should Attend
This educational activity is specifically designed for gastroenterologists, and other healthcare professionals (physicians-in-training, nurses, pharmacists, physician assistants, nurse practitioners, etc.) involved and/or interested in the therapeutic management of patients with IBD.

Objectives

After successful completion of this activity, participants will be better able to:

  • Identify the safety-efficacy profiles and therapeutic potential of current and novel targeted therapies in IBD
  • Recognize how integration of relevant clinical trial data into clinical practice has the potential to enhance outcomes in patients with IBD
  • Integrate health maintenance guidelines such as vaccination, cancer screening as a tool for providing enhanced quality care for patients with IBD
  • Define a rational use of biologics during and after pregnancy and analyze pregnancy outcomes based on the treatment strategy
  • Analyze the emerging role of biosimilars in IBD pertaining to their regulatory approval pathway, extrapolation and interchangeability
  • Identify strategies to guide the transition of care from pediatric to adult patients with IBD